At lower concentrations, METH decreases LTP. by Jarod Swant (246454)

“…At 0.1 µM METH, LTP was 1.58±.08 [<i>n</i> = 13(5)] (Fig. 1B); at 1 µM METH, LTP was 1.50±.07 [<i>n</i> = 13(7)] (Fig. 1C); at 10 µM METH, LTP was 1.58±.07 [<i>n</i> = 14(8)] (Fig. 1D); at 30 µM METH, LTP was 1.37±.06 [<i>n</i> = 15(4)] (Fig. 1E); and at 60 µM METH, LTP was 1.32±.24 [<i>n</i> = 4(2)] (Fig. 1E). …”

Phagocytosis is sharply decreased in CF macrophages. by Karin Simonin-Le Jeune (464354)

Imiquimod decreases DFTD cell number in culture in a concentration and time dependent manner. by Amanda L. Patchett (3391931)

Low oscillatory shar stress <i>Arf6</i> heterozygosity decreases Arf6 expression. by Venkateswara R. Gogulamudi (15447428)

RNF5 depletion suppresses PEL xenograft tumor growth and decreases the levels of cell cycle gene expression and hedgehog signaling in tumors. by Xiaojuan Li (351842)

Tetrandrine decreases Mtb antigen presentation. by Elham Karamooz (2584474)

Decreased number of anastomoses in ICAS mice. by Jill M. Roberts (4760685)

Spectral sensitivity (i.e., responses to monochromatic light) of European sea bass. by Richard W. Brill (2337940)

Isoflurane decreased miR-214. by Hailiang Yan (284342)

“…(<b>E</b>) miR-214 decreased Bax expression in a dose-dependent manner. …”

LMP1 decreases mitochondrial respiration. by Michael Hulse (5932112)

Selection frequencies plotted in decreasing order. by Hannah P. Rowe (7830599)

G9a decreases Rhox5 expression. by Mayumi Sugimoto (151133)

G9a decreases Rhox5 expression. by Mayumi Sugimoto (151133)

Decreased immunofluorescence during multiplex staining. by Sandrine Prost (38667)

“…<p>Serial sections were stained with 1 to 5 different markers (Marker 1, MHCII Qdot 705Vivid; Marker 2, HO1 Qdot 605Vivid; Marker 3, CD163 Qdot 565; Marker 4, CD206 Qdot 655Vivid; Marker 5, CD68 streptavidin Qdot 525). …”

PD 98059 decreases the phosphorylation of ERK in HSVEC, but does not restore ATP-induced decrease in endothelial function in RA. by Padmini Komalavilas (402160)

Tethering transiently decreases the singing rate. by Homare Yamahachi (363988)

Decreased tumor size <i>in vivo</i> is achieved by depletion of miR-21 <i>in vitro</i>. by Sara E. Martin del Campo (683602)

GSK343 decreased tumor stemness. by Laura V. Bownes (10276762)

“…(C) COA6 cells were treated with GSK343 (0, 5 μM) for 72 hours. qPCR demonstrated a significant decrease in mRNA abundance of known stemness markers Oct4, Nanog, and Sox2 following GSK343 treatment compared to untreated cells. …”

<i>Escherichia coli</i> Cyclopropane Fatty Acid Synthase:  Is a Bound Bicarbonate Ion the Active-Site Base?^† by Fabienne Courtois (2667262)

“…The kinetic parameters of the rescued mutants were determined, and it is shown that the rescuing effect is due to an increase in <i>k</i>_cat. These data are interpreted by assuming that the <i>E. coli</i> cyclopropane fatty acid synthase specifically binds a bicarbonate ion that is involved in catalysis, as proposed for the <i>M. tuberculosis</i> enzymes, and that mutation of the bicarbonate ligands decreases the affinity for that ion. …”

<i>Escherichia coli</i> Cyclopropane Fatty Acid Synthase:  Is a Bound Bicarbonate Ion the Active-Site Base?^† by Fabienne Courtois (2667262)

“…The kinetic parameters of the rescued mutants were determined, and it is shown that the rescuing effect is due to an increase in <i>k</i>_cat. These data are interpreted by assuming that the <i>E. coli</i> cyclopropane fatty acid synthase specifically binds a bicarbonate ion that is involved in catalysis, as proposed for the <i>M. tuberculosis</i> enzymes, and that mutation of the bicarbonate ligands decreases the affinity for that ion. …”